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Exposure to bacterial lipopolysaccharides (LPS) induces inflammatory signals in salivary glands. We investigated the regulatory
role of phosphodiesterase 4 (PDE4) inhibitor rolipramon inflammatorymediators and cholinergic/adrenergic stimulation-induced
intracellular Ca2+ signaling in salivary acinar and ductal cells. Submandibular gland (SMG) expressed PDE4A through 4D mRNA
and PDE4 was localized in the luminal membrane of SMG. LPS induced Ca2+ signaling and ROS production in SMG. Treatment
with rolipram blocked LPS-induced Ca2+ increase and ROS production.The application of histamine evoked Ca2+ signals and ROS
production, which were attenuated by rolipram in SMG cells. Moreover, LPS-induced NLRP3 inflammasome and cleaved caspase-
1 were inhibited by rolipram. The inhibitory role of rolipram in ROS-induced Ca2+ signaling was mainly observed in acinar cells
and not in ductal cells. Rolipram also protected SMG acinar but not ductal cells from LPS-induced cell membrane damage. In
the case of cholinergic/adrenergic stimulation, carbachol/isoproterenol-induced Ca2+ signals were upregulated by the treatment
of rolipram in SMG. In the case of cAMP-dependent ductal bicarbonate secretion by rolipram, no effect was observed on the
modulation of ductal chloride/bicarbonate exchange activity. Rolipram could suppress the inflammatory signals and could be a
potential therapeutic strategy against LPS-induced inflammation to protect the salivary gland cells.
1. Introduction
The secretion of saliva is mediated by the autonomic ner-
vous system, which modifies the protein composition of
saliva and triggers fluid secretion. The neuronal release of
acetylcholine from parasympathetic nerves plays a central
role in inducing salivary fluid secretion from the salivary
glands [1]. Salivary acinar and ductal functions are regulated
by numerous molecular components and mainly involve
the activation of Ca2+ and cyclic adenosine monophosphate
(cAMP) signaling. Phosphodiesterase (PDE) is an important
enzyme, responsible for the regulation of intracellular cAMP
and cyclic guanosine monophosphate (cGMP) level. It is
well established that enhanced cAMP concentration activates
cAMP-dependent kinase and subsequently triggers exocyto-
sis [2]. PDEs are classified into at least 11 families based on
affinity, specificity, and amino acid sequences [3, 4]. In the
submandibular gland (SMG), PDE isoforms PDE1–PDE5 are
expressed in an age-dependent or tissue-specific manner in
rodents [5]. PDE4 is broadly distributed throughout the body
and identified with four gene products and multiple splice
variants [5, 6]. The hydrolytic activity of PDEs is important
for themodulation of various cellular functions. For example,
the involvement of PDE4 has been studied in the release
of amylase from parotid acinar cells [7]. Targeting of PDE5
is associated with 𝛽-adrenergic receptor-stimulated mucin
secretion in SMG cells [8]. However, in tissues except the
salivary tissue, the functional significance of PDE isoforms
with differential expression and specificity for any species or
any tissue is not completely understood.
Lipopolysaccharides (LPS) are characteristic components
of the bacterial cell wall and stimulate host cells of the innate
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immune systemvia theToll-like receptor 4 (TLR4), amember
of the Toll-like receptor protein family. TLR signaling is asso-
ciated with the adaptive immune system and the initiation
of inflammatory responses. Enhanced TLR4 expression is
involved in Sjo¨gren’s syndrome (SS) [9] and inflammatory
intestinal bowel diseases such as Crohn’s disease [10]. More-
over, we previously provided evidences that TLR4 signal-
ing is critically involved in the proinflammatory cytokine
expression in gingival fibroblasts and periodontal ligament
fibroblasts [11, 12]. Recently, Dusad et al. demonstrated that
repetitive intranasal inhalant exposures to LPS resulted in sig-
nificant bone deterioration [13].Microbial infection and non-
infectious stimuli trigger the activation of inflammasome, the
protein complex consisting of NOD-like receptors (NLRs)
family, pyrin domain containing-3 (NLRP3, known as cry-
opyrin, CIAS1, or NALP3), apoptosis-associated speck-like
protein containing a CARD (ASC), and caspase-1, as the crit-
ical components of innate immune response [14]. The acti-
vated inflammasome complex leads to the secretion of proin-
flammatory mediators such as interleukin-1𝛽 (IL-1𝛽) and IL-
18, which cause cell damage [15]. It has also been reported that
NLRP3 inflammasome-P2X7 receptor complex is involved in
the inflammatory response in primary SS patients [16]. How-
ever, little is known about NLRP3 inflammasome activation
by pathological stimulation in salivary glands.
Oxidative stress induced by reactive oxygen species
(ROS) is a major risk factor that participates in various cel-
lular functions including salivary gland dysfunction [17].
Several studies have demonstrated that ROS has significant
capacity tomediate cell apoptosis [18, 19].TheTLR4 signaling
triggered by LPS enhances ROS production throughNADPH
oxidase [20, 21]. The stimulation of TLR4 by LPS as an oral
pathogen triggers an increase in intracellular Ca2+ concentra-
tion ([Ca2+]i) and results in inflammatory reaction and
enhanced inflammatory cytokine expression as well as
NLRP inflammasome activation as mentioned above. PDE4
inhibitors have anti-inflammatory and antioxidant effect;
for example, the PDE4 inhibitor roflumilast attenuates LPS-
induced inflammatory mediators in macrophages [22].
Another type of PDE4 inhibitor rolipram possesses antiox-
idant potency against the modulation of formyl-methionine-
leucine-phenylalanine- (fMLP-) induced superoxide anion
release in bronchoalveolar lavage cells [23].
The functional role of PDE4 inhibitor is associated with
the cAMP-dependent mechanism. The costimulation with
𝛽-adrenergic agonist isoproterenol and rolipram enhanced
amylase secretion in parotid acinar cells [7]. Ductal fluid and
HCO
3
− secretion are regulated by the luminal and basolateral
membrane-associated ion transporters [2]. In addition to
the antioxidative effect of rolipram, the enhanced cAMP
level induced by rolipram may be involved in the synergistic
stimulation of neuronal input signal and ductal bicarbonate
secretion. However, little is known about the expression pat-
tern of PDE4 and the inhibitory effect of the PDE4 inhibitor
rolipram on the inflammatory mediator-induced signals in
salivary glands. In addition, the regulatory role of rolipram
on neuronal agonist-induced signals and cAMP-mediated
ductal bicarbonate secretion in salivary glands should be
clarified. In this study, we investigated the multifunction
of rolipram in inflammatory mediators/neuronal agonist-
induced signaling andmodulation of NLRP3 inflammasome.
Moreover, we explored whether rolipram modulates cAMP-
dependent chloride/bicarbonate exchange activity in ductal
bicarbonate secretion in isolated mouse SMG cells.
2. Material and Methods
2.1. Reagents. Fura-2-acetoxymethyl ester (Fura-2-AM)
and 2󸀠,7󸀠-bis-(carboxyethyl)-5-(and-6)-carboxyfluorescein-
(BCECF-) AM were purchased from Teflabs (Austin, TX). 3-
Aminobenzamide (3-AB), histamine, LPS from Pseudomonas
aeruginosa serotype 10, rolipram, carbamyl choline chloride
(carbachol), isoproterenol, hydrogen peroxide, trypsin inhib-
itor, sodium pyruvate, bovine serum albumin (BSA), 𝛽-actin
antibody, and all other chemicals not mentioned here were
purchased from Sigma. Phosphate-buffered saline (PBS),
Pluronic F-127 (20% in DMSO), goat serum, E-cadherin
antibody, ZO-1 antibody, PARP-1 antibody, and MQAE dye
were purchased from Invitrogen (Carlsbad, CA). PDE4 and
caspase-1 antibodies were purchased from Fabgennix (Frisco,
TX) and Abcam (Cambridge, MA), respectively. Collagenase
P was purchased from Roche (Basel, Switzerland).
2.2. Isolation of Mouse SMG Cells. All procedures for main-
taining the mice and for the isolation of acini and ducts
followedGachonUniversity guidelines and were approved by
the Animal Care and Use Committee of Gachon University.
SMG isolated from 30–35 g Balb C wild-type mice were
washed and resuspended in physiological salt solution (PSS)
containing 140mM NaCl, 10mM glucose, 1mM MgCl
2
,
5mM KCl, 10mM HEPES and 1mM CaCl
2
, pH 7.4, 0.02%
soybean-trypsin inhibitor, 0.1% sodium pyruvate, and 0.1%
BSA and kept on ice until use. Briefly, the minced SMG was
incubated in physiological salt solution A (PSA) containing
2.5mg/10mL collagenase P (Roche) for 8min at 37∘C. The
digest was washed with PSA for three times, resuspended in
PSA, and kept on ice until use.
2.3. Measurement of Intracellular Ca2+ Concentration
([Ca2+]
𝑖
). Isolated SMG cells were transferred onto cover
glasses and incubated with 4𝜇M Fura-2-AM in the presence
of 0.05% Pluronic F-127 for 45min for SMG cells in PSS
at room temperature in the dark and then washed for
10min with PSS. Changes in [Ca2+]i were determined by
measuring the fluorescence intensities using dual excitation
wavelengths, 340 and 380 nm, and an emission wavelength
of 510 nm. Results are presented as fluorescence (F) ratios
(Ratio = F
340/380
). Emitted fluorescence was monitored using
a CCD camera (Photometrics, AZ) attached to an inverted
microscope (Olympus, Japan) and analyzedwith aMetaFluor
system (Molecular Devices, PA). Fluorescence images were
obtained at 1 sec intervals and the background fluorescence
at each excitation wavelength was subtracted from raw sig-
nals. ΔCa2+ responses were calculated by dividing the
maximum Ca2+ peak of agonist in the presence of rolipram
by the maximum Ca2+ peak of agonist stimulation.
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Table 1
Genes Tm (∘C) Sequences (5󸀠 → 3󸀠)
TLR-4 50 ATG ATG CCT CCC TGG CTC
CCG CGG TTC TCC TCA GGT C
PDE4A 58 TTC AAG CTG CTG CAA GAA GA
TTC CTG AGG ACC TGG ATA CG
PDE4B 58 GAA CAA ATG GGG CCT TAA CA
TTG TCC AGG AGG AGA ACA CC
PDE4C 58 CAT GCT CAA CCG TGA GTT GT
TGG AAC GTC TTG AGG AGG TC
PDE4D 58 GGA GCT TGT CAC CTT CTT GG
GTG GGC TTT AAG TTG CTC CA
H1R 62 GAC TGT GTA GCC GTC AAC CGG A
TGA AGG CTG CCA TGA TAA AAC C
H2R 60 TCG TGT CCT TGG CTA TCA C
CTT TGC TGG TCT CGT TCC T
H3R 62 TCA GCT ACG ACC GCT TCC TGT CGG TCA C
TTG AGT GAG CGC GGC CTC TCA GTG CCC C
H4R 60 GAA TTG TCT GGC TGG ATT AAT TTG CTA ATT TG
AAG AAT GAT GTG ATG GCA AGG ATG TAC C
NLRP-3 65 CTC TGT GAG GGG CTT CTG CAC
GGC ACC TGG TGG TCC TGC TTC
GAPDH 58 TTA GCC CCC CTG GCC AAG
CTT ACT CCT TGG AGG CCA TG
2.4. Intracellular pH (pH
𝑖
) Measurements. pHi was measured
with BCECF at dual excitation wavelengths of 495 nm and
440 nm. BCECF fluorescence was read at emission wave-
lengths above 530 nm. Isolated SMG cells attached onto
coverslips were loaded in the chamber with BCECF in the
presence of 0.05% Pluronic F-127 for 15min incubation with
PSS at room temperature with 6 𝜇M BCECF-AM. After
stabilizing the fluorescence, the cells were perfused with PSS
for at least 5min before measuring pHi at 37
∘C. CBE activity
was measured by incubating the cells with CO
2
-saturated
HCO
3
−-buffered media to acidify the cytosol. CBE activity
was initiated by perfusing the cells with Cl−-free HCO
3
−-
buffered media containing 140mM Na+. The emitted fluo-
rescence was monitored with a CCD camera (Photometrics,
Tucson, AZ) attached to an inverted microscope (Olympus,
Japan) and analyzed with a MetaMorph system (Molecular
Devices, PA). Fluorescence images were obtained at 1 sec
intervals and the background fluorescence was subtracted
from the raw background signals at each wavelength. CBE
activity was determined from the slopes and the derivatives
of the first 30–45 sec of pHi increases.
2.5. Confocal Imaging. Experiments were performed with
sliced SMG tissues and isolated SMG acinar and ductal
clusters were evaluated for the localization of E-cadherin.
Isolated submandibular acini and ducts were plated on glass
coverslips for 5min at room temperature prior to fixation
with chilled (−20∘C) methanol. After fixation, immunostain-
ing was performed as described previously [24] using 1 : 100
dilution of the E-cadherin and ZO-1 antibodies. Briefly, the
cells were incubated with the primary antibodies overnight at
4∘C and after washing unbound antibodies with 5% BSA/PBS
for three times, the bound antibodies were detected with goat
anti-rabbit immunoglobulin G (IgG) tagged with fluorescein
isothiocyanate (FITC) (E-cadherin and ZO-1) and then
washed with PBS for three times. Coverslips were mounted
on glass slides with Fluoromount-GTM including DAPI
(Electron Microscopy Sciences, Hatfield, PA) and analyzed
using a LSM 700 Zeiss confocal microscope (Germany) with
ZEN software. To determine the normalized intensity of E-
cadherin in each image, average intensity of E-cadherin was
divided by region of interest (ROI). Images were collected
from four to five separate preparations of acinar and ductal
cells and results are the averages from all experiments.
2.6. Reverse Transcription-Polymerase Chain Reaction (RT-
PCR). Total RNA was extracted from isolated SMG cells
using TRIzol extraction system from Invitrogen according
to the manufacturer’s instructions. Total RNA was amplified
according to the manufacturer’s protocol using TOPscript™
one-step RT-PCR kit from Enzynomics (Daejeon, South
Korea). The primers used are listed in Table 1. The PCR was
started with a denaturation step at 95∘C for 5min, followed
by 35 cycles at 95∘C for 1min, an annealing step for 1min, an
extension step at 72∘C for 1min, and a final extension step at
72∘C for 10min. The PCR products were electrophoresed on
1% agarose gels.
2.7. Measurement of Reactive Oxygen Species (ROS) Produc-
tion. To measure the ROS production in isolated SMG cells,
Oxiselect intracellular ROS assay kit with green fluorescence
(Cell Biolabs, CA) was used. SMG cells were suspended in
PSA solution.The cellswere attached to a 96-well plate treated
with 0.005% poly-L-lysine (Sigma). Cells were incubated
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with 100 𝜇L DCFH-DA-containing media at 37∘C for 1 hr
and washed with PBS for three times. After discarding last
PBS, the cells were treated with 20𝜇g/mL LPS, 100 𝜇M
histamine, and 100 𝜇M H
2
O
2
in the presence or absence
of 10 𝜇g/mL rolipram for 1 hr at room temperature. Then,
the cells were washed with PBS for three times and lysed
with PSA solution-containingCell Lysis Buffer (Cell Biolabs).
After incubation for 5min, cell lysate was transferred to a new
96-well plate. The DCF fluorescence of the plate was mea-
sured with VICTO3 (PerkinElmer, MA) at 485 nm/535 nm
(excitation/emission) wavelengths. To calculate DCF con-
centrations from plate, a standard curve was plotted as per
the manufacturer’s instructions (Cell Biolabs). The value of
absorbance was substituted for the 𝑦-variable in the equation
of standard curve.
2.8. Intracellular Cl− (𝐶𝑙−
𝑖
) Measurements. Intracellular Cl−
was evaluated from N-(ethoxycarbonylmethyl)-6-methox-
yquinolinium bromide (MQAE) fluorescence. The SMG
ductal cells on the coverslip were loaded with MQAE by
30min of incubation at room temperature in bath solution
containing 5mMMQAE and were washed by perfusion with
NaCl-based solution until stabilization of the baseline signal.
The MQAE fluorescence was recorded for at least 3min to
obtain the baseline and then switched perfusion solution
with 0mMCl− (0Cl−).Then 126mMCl− (126Cl−) containing
HCO
3
− bath solution was added back. MQAE fluorescence
was recorded at an excitation of 360 nm and light emitted
at a wavelength higher than 530 nm was collected with a
CCD camera (Photometrics). Images were analyzed with a
MetaMorph system (Molecular Devices).
2.9.Western Blotting. SMG cells were isolated and stimulated
with indicated components for 1 hr. Cell lysates were prepared
in lysis buffer (containing 20mM Tris, 150mM NaCl, 2mM
EDTA, 1% TritonX-100, and a protease inhibitor mixture)
by passing 15–18 times through a 27-gauge needle after
sonication. The lysates were centrifuged at 11,000×g for
20min at 4∘C, and protein concentration in the supernatants
was determined. Proteins were denatured by heating in SDS
sample buffer at 37∘C for 30min. The 30 𝜇g heated protein
samples were subjected to SDS-PAGE and transferred to
methanol-soaked polyvinylidene difluoride (PVDF) mem-
branes. Transferred proteins on PVDFmembranes were visu-
alized with caspase-1 (Abcam) and 𝛽-actin (Sigma) antibod-
ies by enhanced luminescent solution (Thermo Scientific).
2.10. Statistical Analyses. Data from the indicated number
of experiments were expressed as mean ± SEM. Statistical
significance was determined by analysis of variance in each
experiment. A value of ∗𝑃 < 0.01 was considered statistically
significant.
3. Results
3.1. Rolipram Inhibits LPS- and Histamine-Induced [Ca2+]
𝑖
Signaling in Mouse SMG Acinar Cells. To evaluate the inhib-
itory role of rolipram in inflammatory mediator signaling,
RT-PCRwas used to assess the expression of PDE4 subfamily,
TLR4, andhistamine receptors (HR) inmouse SMGcells. Pri-
marily isolated SMG acinar cells expressed PDE4A through
PDE4D, TLR4, andH1RmRNA (Figure 1(a)). It will be of par-
ticular interest to determine the localization of PDE4, which
may regulate cAMP-dependent cellular functions. Thus, we
evaluated the protein expression of PDE4 in SMG tissues and
isolated cells. Interestingly, PDE4 is localized in the luminal
membrane of acini and ducts. Expression of PDE4 isoforms
was not modulated in the presence of rolipram (Figure 1(a)).
To evaluate whether the modulatory effect of rolipram was
mediated by TLR4 activation in isolated SMG acinar cells,
LPS-induced [Ca2+]i measurement was performed in the
absence or presence of rolipram. Pretreatment of rolipram
inhibited LPS-induced [Ca2+]i peak (𝑛 = 4, Figure 1(b)).
Rolipram per se did not increase [Ca2+]i response (data
not shown). The inhibited [Ca2+]i response by rolipram
is depicted in Figure 1(c). These results show that LPS-
triggered [Ca2+]i response significantly (𝑃 < 0.01) decreased
in the presence of rolipram. Similarly, rolipram inhibited
histamine-evoked [Ca2+]i response (𝑛 = 3, Figures 1(d) and
1(e)). These results show that rolipram has strong inhibitory
effect on the inflammatorymediator-induced [Ca2+]i signals.
3.2. Rolipram Prevents H2O2-Induced [Ca2+]𝑖 Signals and
Intracellular ROS Production in SMG Acinar Cells. Since
inflammatory mediators can recruit ROS-mediated signal,
H
2
O
2
-evoked [Ca2+]i mobilization was evaluated in the
presence of rolipram in the salivary glands. To examine
the antioxidative role of rolipram, SMG acinar cells were
stimulated with 10mM H
2
O
2
in the presence or absence
of rolipram. The H
2
O
2
-induced [Ca2+]i increase was sig-
nificantly inhibited by rolipram (𝑛 = 4, Figures 2(a) and
2(b)). Preincubation of human salivary gland (HSG) cells
with the ploy NAD+-metabolite ADP-ribose polymerase-
1 (PARP-1) inhibitor 3-AB significantly decreased H
2
O
2
-
induced [Ca2+]i increase [25]. Similarly, in the present study,
the H
2
O
2
-induced [Ca2+]i signaling in mouse SMG cells was
attenuated by 3-AB (𝑛 = 4, Figures 2(c) and 2(d)). PARP-1was
localized in the cytosol and predominantly in SMG cell nuclei
(Figure 2(e)). These results suggest that rolipram attenuates
H
2
O
2
-induced [Ca2+]i increase in SMG acinar cells. To
determine whether rolipram inhibits ROS production, whole
SMG cells including ductal cells were stimulated with inflam-
matory mediators LPS, histamine, and H
2
O
2
for 30min and
the DCF fluorescence intensities were measured. Rolipram
inhibited LPS- and histamine-induced ROS production as
well as the resting ROS level; however, rolipram moderately
inhibited H
2
O
2
stimulation (𝑛 = 3, Figure 2(f)).
3.3. Differential Role of Rolipram in SMG Acinar and Ductal
Cells. While rolipram significantly inhibited the inflamma-
tory mediator-induced [Ca2+]i response, its effect on H2O2
stimulation was not marked. Accordingly, we compared
the effect of rolipram on H
2
O
2
-induced [Ca2+]i response
between acini and ductal cells. Interestingly, rolipram inhib-
ited H
2
O
2
-induced [Ca2+]i response of acinar cells but
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Figure 1: Rolipram inhibits LPS- and histamine-induced [Ca2+]i signaling in mouse SMG acinar cells. (a) mRNA expression of PDE4
subfamily 4A through 4D and localization of PDE4 (red) in SMG tissue (left) and isolated cells (right). Arrow heads (duct) and arrows (acini).
mRNA expression of TLR4 and histamine receptors (H1R to H4R) in SMG cells and expression of PDE4A through 4D in the presence of
rolipram. (b) Changes in [Ca2+]i induced by 20 𝜇g/mL LPS (gray trace) and pretreatment with 10 𝜇g/mL rolipram (black trace including
arrow which indicates rolipram-stimulated time course) in SMG acinar cells. The traces are averaged trace (𝑛 = 4). The upper bars indicate
the extracellular solutions applied to the cells. (c) Analysis of LPS-inducedmaximum [Ca2+]i peak as determined using R340/380 fluorescence
ratios (∗𝑃 < 0.01) and means ± SEMs. (d) Changes in [Ca2+]i induced by 100 𝜇M histamine (gray trace) and pretreatment with 10𝜇g/mL
rolipram (black trace including arrow which indicates rolipram-stimulated time course) in SMG acinar cells. The traces are averaged trace
(𝑛 = 3). The upper bars indicate the extracellular solutions applied to the cells. (e) Analysis of histamine-induced maximum [Ca2+]i peak as
determined using R340/380 fluorescence ratios (∗𝑃 < 0.01) and mean ± SEMs.
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Figure 2: Rolipram prevents H
2
O
2
-induced [Ca2+]i signals and intracellular ROS production in SMG acinar cells. (a) Changes in [Ca
2+]i
induced by 1mM H
2
O
2
. Changes in [Ca2+]i induced by 1mM H2O2, pretreatment with 10𝜇g/mL rolipram (b) and with 10 𝜇M 3-AB (c).
The traces are averaged traces (𝑛 = 4). The upper bars indicate the extracellular solutions applied to the cells. (d) Analysis of H
2
O
2
-induced
maximum [Ca2+]i peak as determined using R340/380 fluorescence ratios (
∗
𝑃 < 0.01). (e) Expression of PARP-1 (green) in SMG tissue. (f)
Effect of inflammatory mediators for 30min in the absence or presence of rolipram (R) on intracellular ROS production in SMG cells. Results
are expressed as ratio of control and mean ± SEMs are shown (𝑛 = 3, ∗𝑃 < 0.01 compared with control).
showed no effect on that of ductal cells (Figure 3(a)). To fur-
ther demonstrate the role of rolipram as shown in Figure 3(b),
the cells were stimulated with LPS to induce cell membrane
damage and stained with the plasma membrane marker E-
cadherin. The notable finding was that the SMG acini cell
membrane was protected by rolipram in the presence of
LPS (Figures 3(b) and 3(c)). It was hard to find ductal cells
after stimulation with LPS (data not shown); however, in the
presence of rolipram, E-cadherin and tight junction marker
ZO-1 staining could be observed at the plasma and apical
membrane, respectively (Figures 3(b)∼3(e)). TLR4 activation
by LPS and subsequent [Ca2+]i increases are necessary for
the activation of the NLRP3 inflammasome [26]. Thus,
to determine the expression of NLRP3 induced by LPS
treatment and the regulatory role of rolipram in expressing
the NLRP3 inflammasome, SMG cells were treated with LPS
for 30min in the absence and presence of rolipram. We
observed for the first time that isolated SMG cells signifi-
cantly expressed NLRP3 in the presence of LPS. As shown
in Figure 3(f), LPS enhanced NLRP3 mRNA expression,
but rolipram attenuated NLRP3 expression. Inflammasome
complex consists of NLRP3, ASC, and caspase-1 [27]. We
confirmed that well-established inflammasome component
caspase-1 was inhibited by rolipram (Figure 3(g)).
3.4. Effect of Rolipram on Synergistic Regulation of Cholinergic
and 𝛽-Adrenergic Stimulation in SMG Cells. In addition to
the anti-inflammatory effect of rolipram, the role of rolipram
in neurotransmitter inputs such as cholinergic/adrenergic
stimulation-induced [Ca2+]i response was evaluated in SMG
acinar and ductal cells; the cells were stimulated with the
muscarinic receptor agonist, carbachol, and the 𝛽-adrenergic
agonist, isoproterenol (Iso) in the absence and presence of
rolipram. In Figures 4(a)–4(d), acinar and ductal cells showed
carbachol/isoproterenol-induced [Ca2+]i peak and plateau
responses except ductal isoproterenol-induced [Ca2+]i
response (Figure 4(e)). These results indicated that cholin-
ergic/adrenergic stimulation-induced [Ca2+]i responses were
enhanced in the presence of rolipram.
3.5. Effect of Rolipram on Chloride/Bicarbonate Exchanger
Activity. The cAMP signaling pathway stimulates epithelial
chloride/bicarbonate exchanger such as luminal solute carrier
26 familymember 6 (SLC26A6) in the duct. Enhanced cAMP
and [Ca2+]i concentration resulted in the synergistic activa-
tion of ion transporters, which induce changes in intracellular
pH (pHi) and directly reflect epithelial fluid secretion [25,
28]. To determine effects of rolipram on the modulation
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Figure 3: Differential role of rolipram in SMG acinar and ductal cells. (a) Changes in [Ca2+]i induced by 10𝜇M H2O2 and pretreatment
with 10𝜇g/mL rolipram in acinar (black trace) and ductal cells (gray trace). (b) Immunofluorescence staining patterns of E-cadherin protein
(green) and DAPI staining (orange) of SMG acinar and ductal cells. The isolated SMG cells were treated with LPS in the absence or presence
of rolipram for 1 hr. (c) Relative intensity of E-cadherin in plasma membrane (PM) fraction divided by the region of interest (ROI). The bars
show the mean ± SEM (𝑛 = 3). (d) Immunofluorescence staining patterns of ZO-1 protein (green) and DAPI staining (orange) of SMG acinar
and ductal clusters indicated experimental condition. (e) Relative intensity of ZO-1 divided by ROI. The bars show the mean ± SEM (𝑛 = 3).
(f) mRNA expression of NLRP3 after the indicated stimulation for 30min. Ratios are expressed as ratio of control and means ± SEMs are
shown (𝑛 = 3, ∗𝑃 < 0.01) compared with PBS. (g) Western blot analysis with caspase-1 after stimulation of indicated condition for 1 hr.
of cAMP-associated ion transporters such as anion exchanger
and solute carrier transporter, we measured the chloride/
bicarbonate exchanger activity in ductal cells. The chloride/
bicarbonate exchanger activity was evaluated by measuring
the changes in pHi induced by acute chloride removal and
subsequent addition of chloride (Figures 5(a) and 5(b)).
Removal of chloride in the perfused solution induced intra-
cellular alkalinization in ductal cells. The slope of the change
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Figure 4: Effect of rolipram on synergistic regulation of cholinergic and 𝛽-adrenergic stimulation in SMG cells. Changes in [Ca2+]i induced
by 10𝜇M carbachol (gray trace) and pretreatment with 10𝜇g/mL rolipram (black trace) in SMG acinar (a) and ductal (b) cells. (c) Analysis of
carbachol-induced maximum [Ca2+]i peak and plateau from baseline as determined using R340/380 fluorescence ratios in acini and ductal
cells. Changes in [Ca2+]i induced by 100𝜇M isoproterenol (gray trace) and pretreatment with 10𝜇g/mL rolipram (black trace) in SMG acinar
(d) and ductal (e) cells. All traces were averaged. (f) Analysis of isoproterenol-induced maximum [Ca2+]i peak and plateau from baseline as
determined using R340/380 fluorescence ratios in acini and ductal cells. The upper bars indicate the extracellular solutions applied to the
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Figure 5: Effect of rolipram on chloride/bicarbonate exchanger activity. (a) Changes in intracellular pH (pHi) in the ductal cells in the
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in pHi effect was measured using chloride-free bicarbonate-
buffered solution. We confirmed chloride movement with
chloride-sensitive dye MQAE in ductal cells (Figure 5(c)). As
shown in Figure 5, the slope of pHi as chloride/bicarbonate
exchanger activity and chloride movement in the presence of
rolipram did not show any statistical difference.
4. Discussion
In this study, we demonstrated the regulatory effect of PDE4
inhibitor rolipram on Ca2+ signaling and ROS production
induced by the stimulation of inflammatory mediators in
acinar and ductal cells isolated from mouse submandibular
salivary glands. Additionally, various PDE4 subfamilies have
been reported to be present in mouse submandibular glands
and PDE4 was localized in the luminal membrane of acini
and ducts. Rolipram has been developed and studied as a
potent antidepressant, which elevates rat brain cAMP in vivo
[29, 30]. PDE family members degrade cAMP, and they
are expressed fundamentally in all immune cells including
neutrophils, eosinophils, lymphocytes, and macrophages.
The anti-inflammatory role of PDE inhibitor rolipram on
immune cells is well established, whereas the role of rolipram
on salivary glands has been addressed in cAMP-dependent
amylase secretion [5, 7]. Regulation of inflammatory signal
and cAMP-dependent electrolyte secretion by rolipram in
salivary gland remains unknown. Moreover, there are no
previous reports indicating the effect of rolipram on inflam-
matory mediators or cholinergic/adrenergic-induced sig-
naling and cAMP-dependent bicarbonate secretion in the
salivary glands.
In the present study, we focused on the inhibitory effect of
rolipram on inflammatory mediator-induced [Ca2+]i signal-
ing and ROS production. In the presence of rolipram, LPS or
histamine-induced [Ca2+]i signaling was dramatically atten-
uated in mouse SMG acinar cells. In addition, H
2
O
2
-induced
[Ca2+]i signaling was inhibited by rolipram. Pretreatment of
rolipram increased cAMP concentration and subsequently
may activate protein kinase A (PKA), leading to reduction
of ROS production and, moreover, may block the [Ca2+]i
signaling cascade. However, how to acutely attenuate [Ca2+]i
signaling by rolipram and its signaling mechanism should be
clarified in coming years. LPS-induced oxidative stress was
addressed by ROS through NADPH oxidase (Nox). TLR4
recruits the Nox4 and then is able to generate ROS in the
form of H
2
O
2
[31]. Sustained Ca2+ level triggers mitochon-
drial damage including increased mtROS production [32].
Although the candidate of ROS source was most likely Nox4,
we cannot rule out the mitochondrial ROS source.
The TLR signaling results in the production and expres-
sion of inflammatory mediators including IL-6 and IL-
8 in the salivary glands [9]. Normal human SMG cells
expressed TLR1-10 mRNA and salivary glands of patients
with SS showed enhanced expression of TLR2, TLR3, and
TLR4 [9, 33]. Stimulation of human salivary gland cells
with TLR ligands augmented the expression of inflammatory
cytokines such as IL-6 and CD54 and further cell apoptosis,
which means TLR signaling may be involved in pathological
process in SS [9]. We provided the first evidence that TLR-
mediated [Ca2+]i signal is associated with the enhanced gene
expression of NLRP3 inflammasome, which is attenuated by
rolipram in SMG cells (Figure 3(f)) and cleaved caspase-
1 signaling was inhibited (Figure 3(g)). LPS signaling and
generation of ROS are common events in NLRP3 inflamma-
some activation. Although ligand ofNLRP3 inflammasome is
unclear, enhanced cAMP production inhibited the activation
of the NLRP3 inflammasome through the direct regulatory
role of cAMPon theNLRP3 complex [26].We speculated that
the increased cAMP by rolipram might inhibit the activation
of inflammasome. However, further studies investigating the
precise role of rolipram and the possible involvement of
PDE in the inflammasome complex such as thioredoxin-
interacting protein TXNIP and adaptor protein ASC should
be carried out.
It is noteworthy that rolipram, which regulates intracel-
lular cAMP levels and inhibits the inflammatory signaling,
may be applied in systemic autoimmune diseases such as SS
and acute bacterial infection. In addition to the regulatory
role of rolipram on the inflammatory mediators in this study,
rolipram enhanced the amylase release by 𝛽-adrenergic stim-
ulation in parotid glands [7]. Fluid and protein secretion from
the salivary gland due to signals such as neurotransmitters
input are determined by coordinated spatial and temporal
modulation of Ca2+ signaling mechanism. Moreover, the
magnitude or spatial and temporal regulation of Ca2+ sig-
naling is important for the stimulation and maintenance of
fluid secretion [34]. Cholinergic/𝛽-adrenergic stimulations
by carbachol/isoproterenol-induced [Ca2+]i signaling were
enhanced in the presence of rolipram in Figure 4, suggest-
ing that enhanced cAMP caused by rolipram and [Ca2+]i
concentration by carbachol/isoproterenol results in the syn-
ergistic activation for fluid secretion. It has been reported
that amylase secretion is regulated by cAMP and [Ca2+]i,
which mediate the enhanced secretion by combined stim-
ulation [35]. Generally, high Ca2+ microdomain at luminal
membrane is essential to drive protein and fluid secretion
[24]. Localization of PDE4 at apical membrane as shown in
Figure 1(a) may ensure the fidelity and rapid activation for
protein secretion by regulating the local cAMP level.
Ca2+ and cAMP are debatably the classical second mes-
sengers that control various types of cellular homeostasis
[36]. The cAMP pathway augments Ca2+ signals by phos-
phorylation of IP
3
receptors [37]. The Ca2+ signal itself stim-
ulates Ca2+-dependent adenylyl cyclases [36]. Synergism of
Ca2+ and cAMP signaling induces epithelial fluid secretion
[28]. Neurotransmitter signaling such as cholinergic and
muscarinic receptor activation might be integrated with syn-
ergism to control the physiological response through cAMP-
PKA mechanism, whereas the signaling through histamine
or LPS did not mediate in this mechanism. In salivary
glands, histamine stimulation transfers its signal through H1
receptor, which is independent signaling with PKA and the
LPS signal was inhibited by PKA in the pretreatment with
rolipram. Otherwise, it is possible that the upstream mecha-
nismof PKAmight be involved. Although the differential role
of PKA in both neuronal input and inflammatory signaling
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pathway should be elucidated, rolipram is an effective agent,
which modulates those two signaling pathways.
In the present study, we did not observe significantly
altered chloride/bicarbonate exchange activity for bicarbon-
ate secretion in ductal cells, suggesting the effect of rolipram
is more associated with acinar cells than ductal cells. The cel-
lular distribution or expression level of PDE family including
PDE4 between SMG acinar and ductal cells may be different
and should be correlated with their function. Although the
exact expression of other PDE isoformsmight be determined
in the coming years, the ductal cells were dominantly dam-
aged by oxidative stress and showed no statistical difference
in the chloride/bicarbonate exchanger activity with enhanced
cAMP level by rolipram, suggesting that the duct may require
other PDE family members for fluid secretion or possess
more sensitivity to oxidative stress than acini. Moreover, the
significance of the different PDE4 isoforms in the effect of
rolipram needs to be clarified. Rolipram possessed different
inhibitory action onductal versus acinar cells in the treatment
with H
2
O
2
. The antioxidative capacity between ductal and
acinar cells not differential inhibitory action of rolipram
should be different. The differential identification of ROS
scavenging system and oxidative-dependent channels should
be clarified between ductal and acinar cells.
Additionally, we cannot rule out longer treatment of
rolipram. It has been proposed that long-term administration
up to 2 months of calcineurin inhibitors decreases antiox-
idant enzyme activity and alters saliva composition [38].
Similarly, the administration of high dose of PDE inhibitor
ICI 153,110 for up to 6 months influenced the epithelial
cell proliferation including salivary glands [39]. Accordingly,
long-term administration of roliprammay result in decreased
redox control, as reflected by the enhanced antioxidative
role of rolipram. In the current study, although we did not
examine the long-term administration of rolipram, the
involvement of PDE4 was found to modulate acute TLR-
mediated [Ca2+]i signaling and ROS production.
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